Registration 333-295712
S-4/A · 2026-08-03 · 0001213900-26-084576
Terms from the governing filing for this registration; not a claim that the offering is open today.
Company research
DRC Medicine Inc.
CIK 2086412Updated Nov 10, 2026
Filing activity
Latest filing
13 filings on record · SP 15D2, 425, 424B3, EFFECT, S-4/A, S-4.
Recent filings
Show 5 more recent filings
Offerings
Registration 333-295712
Registration 333-295712-01
Filing attachments
ea025421719ex99-1.htm · S-4/A · 2026-07-20
EX-99.1 7 ea025421719ex99-1.htm CONSENT OF AKIRA OKADA TO BE NAMED AS A DIRECTOR Exhibit 99.1 Consent to be Named as a Director Nominee In accordance with Rule 438 promulgated under the Securities Act of 1933, as amended, I hereby consent to my being named in the Registration Statement on Form S-4 of DRC Medicine Inc., a Delaware corporation (the “Company”), filed with the Securities and Exchange Commission, and all amendments (including post-effective amendments) thereto (the “Registratio…
Read attachment ↗ea025421719ex99-2.htm · S-4/A · 2026-07-20
EX-99.2 8 ea025421719ex99-2.htm CONSENT OF SHIGEO KAMITSUJI TO BE NAMED AS A DIRECTOR Exhibit 99.2 Consent to be Named as a Director Nominee In accordance with Rule 438 promulgated under the Securities Act of 1933, as amended, I hereby consent to my being named in the Registration Statement on Form S-4 of DRC Medicine Inc., a Delaware corporation (the “Company”), filed with the Securities and Exchange Commission, and all amendments (including post-effective amendments) thereto (the “Regist…
Read attachment ↗